Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Chu T, Jiang L, Ying W, Han B. M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC. Clinical and Translational Oncology. 2016 Jul 28;19(3):326–31. doi: 10.1007/s12094-016-1533-x.